Invention Grant
- Patent Title: Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides
-
Application No.: US15171018Application Date: 2016-06-02
-
Publication No.: US10052382B2Publication Date: 2018-08-21
- Inventor: Darell Bigner , Chien-Tsun Kuan , Ira H. Pastan , Hailan Piao
- Applicant: Duke University , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH
- Applicant Address: US NC Durham US DC Washington
- Assignee: Duke University,The United States of America as Represented by the Secretary of Health (NIH)
- Current Assignee: Duke University,The United States of America as Represented by the Secretary of Health (NIH)
- Current Assignee Address: US NC Durham US DC Washington
- Agency: Banner & Witcoff, Ltd.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K51/10 ; C07K16/30 ; C07K16/44 ; G01N33/574 ; A61K47/68 ; A61K39/00

Abstract:
High affinity antibodies were made to gangliosides expressed on tumor cells. The antibodies can be used analytically, diagnostically, therapeutically, and theranostically. The antibodies may be used to target cytotoxic reagents to tumor cells, thus minimizing full-body toxicity. The antibodies may also be used with out added cytotoxin. The antibodies may be detectably labeled or labelable for analytic and diagnostic purposes. The combination of specificity and affinity of the antibodies render them particularly useful.
Public/Granted literature
- US20160272730A1 Antibodies for Tumor Gangliosides Public/Granted day:2016-09-22
Information query